Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
08/2005
08/11/2005WO2005025514A3 Compounds that modulate neuronal growth and their uses
08/11/2005WO2005025492A3 Novel compositions, pharmaceutical compositions, and methods for the treatment and prevention of heart disease
08/11/2005WO2005023197A8 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas
08/11/2005WO2005023188A3 Compounds and methods
08/11/2005WO2005020931A3 Systems and methods for treating hemorrhoids
08/11/2005WO2005020886A3 Identification and use of cofactor independent phosphoglycerate mutase as a drug target
08/11/2005WO2005007120A8 System and method for treating nausea and vomiting by vagus nerve stimulation
08/11/2005WO2005002501A3 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same
08/11/2005WO2005000233A3 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
08/11/2005WO2004112698A3 Methods for obtaining anti-retroviral agents
08/11/2005WO2004103314A3 Polyol polyester-containing personal care products that do not contain low viscosity silicone fluids
08/11/2005WO2004103312A3 Peptides useful as hiv fusion inhibitors
08/11/2005WO2004103276A3 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/11/2005WO2004091480A3 Tie-2 modulators and methods of use
08/11/2005WO2004089300A3 Sapphyrins and uses thereof
08/11/2005WO2004082635A3 Methods and compositions related to joint inflammation diseases
08/11/2005WO2004078126A3 Compositions and methods with enhanced therapeutic activity
08/11/2005WO2004066917A3 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites
08/11/2005WO2004060309A3 Methods of treating and/or preventing autoimmune diseases
08/11/2005WO2004056315A3 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
08/11/2005WO2004047721A3 A process for preparation of an agglutination reagent for rapid detection of typhoid
08/11/2005WO2004043407A3 Methods and products for treating staphylococcal infections
08/11/2005WO2004012683A3 Novel druggable regions in set domain proteins and methods of using the same
08/11/2005WO2003088899A3 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
08/11/2005US20050176964 Nicotinamide derivatives useful as p38 inhibitors
08/11/2005US20050176825 a mixture of quinic acid and salts, and nontoxic inert carriers or diluents; solvent extraction
08/11/2005US20050176775 Substituted pyridinones
08/11/2005US20050176748 Vinorelbine derivatives
08/11/2005US20050176696 Synergistic anit-cancer compounds
08/11/2005US20050176690 Administering purine nucleoside for treatment of arthritis inflammation
08/11/2005US20050176668 VPS35-based assays and methods for treating Alzheimer's disease
08/11/2005US20050176646 Covalently bonding a narcotic to a single amino acid or an oligopeptide of 15 or fewer amino acids such that the narcotic does not release into a patient's bloodstream at levels that give rise to a euphoric or overdose level
08/11/2005US20050176626 modulating production of neurons and/or oligodendrocytes from neural progenitor cells of human white matter and to a method of treating a subject for a condition modulated by underproduction of oligodendrocytes from human white matter, sterol inhibitors
08/11/2005US20050176620 Crosslinked compounds and methods of making and using thereof
08/11/2005US20050176130 Functional mutations in respiratory syncytial virus
08/11/2005US20050175715 Cellular depolarization and regulation of matrix metalloproteinases
08/11/2005US20050175695 exhibit biphasic plasma profile with a first plasma concentration peak level within within 14 hours of ingestion and a second plasma concentration peak level within 5-10 hours after ingestion; treats hypertension, congestive heart failure, atherosclerosis, and angina
08/11/2005US20050175616 PCDGF receptor antibodies and methods of use thereof
08/11/2005US20050175541 Enhanced drug delivery
08/11/2005US20050172852 create permanent tissue markings, including, but not limited to, tattoos, that have variable appearance properties. Also, the present invention provides methods for producing, implanting, altering and removing these variable appearance tissue markings.
08/10/2005EP1560597A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
08/10/2005EP1560588A2 Treatment for traumatic synovitis and damaged articular cartilage
08/10/2005EP1560571A2 Edible film for relief of cough or symptoms associated with pharyngitis
08/10/2005EP1560540A2 Methods of treating dry eye disease with lantibiotics
08/10/2005EP1560498A2 Chewing gum compositions with encapsulated stain removing agent
08/10/2005EP1560488A2 Antibacterial agents
08/10/2005EP1069900B1 Use of reboxetine for the treatment of neuropsychiatric disorders
08/10/2005EP0968158B1 Method of preparing substituted indanones, the substituted indanones and metallocenes prepared therefrom
08/10/2005CN1653136A Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith
08/10/2005CN1653082A Platinum complexes having antitumor activity
08/10/2005CN1653064A Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
08/10/2005CN1652820A Methods of treatment using CTLA-4 antibodies
08/10/2005CN1652817A Mycoplasma hyopneumoniae bacterin vaccine
08/10/2005CN1652806A Formulations useful in the treatment of male and female impotence
08/10/2005CN1652788A Method of treating diabetes
08/10/2005CN1651092A Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent
08/10/2005CN1214029C 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroi-soquinol-2-yl)-5-(2-pyridyl) quinazo line mesylat and polymorphs
08/10/2005CN1214013C HIV replication inhibiting pyrimidines
08/10/2005CN1213732C Stable pharmaceutical solution formulations for pressurised metered dose inhalers
08/10/2005CN1213724C Local compsn. contg. tocopherol
08/10/2005CN1213723C Antiperspirant or deodorant composition
08/09/2005US6926885 In-vivo diagnostic method by means of near infrared radiation
08/09/2005CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/04/2005WO2005071070A2 Substances directed against specific sequence essential for heparanase catalytic activity end uses thereof as heparanase inhibitors
08/04/2005WO2005070081A2 Methods of using zonisamide as an adjunctive therapy for partial seizures
08/04/2005WO2005070080A2 Methods of using zonisamide as an adjunctive therapy for partial seizures
08/04/2005WO2005058245A3 Synthetic process
08/04/2005WO2005053605A3 Therapeutic liposomes
08/04/2005WO2005051305A3 Enhanced drug delivery
08/04/2005WO2005048956A3 Estradiol-related compounds and methods of use as anti-tumor agents
08/04/2005WO2005048930A3 Surfactant-based gel as an injectable, sustained drug delivery vehicle
08/04/2005WO2005041863A3 Method for interconnecting longitudinal members extending along a spinal column
08/04/2005WO2005041853A3 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines.
08/04/2005WO2005037216A3 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
08/04/2005WO2005037206A3 Anti-cancer compounds and methods of use thereof
08/04/2005WO2005034867A3 Thioether-substituted benzamides as inhibitors of factor xa
08/04/2005WO2005034865A3 Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
08/04/2005WO2005032464A3 Phenyl pyrrolidine ether tachykinin receptor antagonists
08/04/2005WO2005027827A3 Host defense factor x (hdfx)
08/04/2005WO2005023175A3 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
08/04/2005WO2005020891A3 Monoclonal antibodies against ricin toxin and methods of making and using thereof
08/04/2005WO2005020885A3 Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
08/04/2005WO2005018557A3 Substituted pyridinones
08/04/2005WO2005002516A3 Leukocyte internalized peptide-drug conjugates
08/04/2005WO2004112692A3 Therapeutic herbal compositions
08/04/2005WO2004108093A3 Antiseptic compositions, methods and systems
08/04/2005WO2004108072A3 Delivery of immune response modifier compounds using metal-containing particulate support materials
08/04/2005WO2004105704A3 Emulsion base for skin care compositions
08/04/2005WO2004098533A3 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
08/04/2005WO2004093807A3 Somatostatin vectors
08/04/2005WO2004089295A3 Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation
08/04/2005WO2004089283A3 Compositions and methods for treating viral infections
08/04/2005WO2004087070A3 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-FUNGAL AGENTS
08/04/2005WO2004080385A3 Compositions and methods for diagnosing and treating an inflammation
08/04/2005WO2004075840A9 Selective non-steroidal glucocorticoid receptor modulators
08/04/2005WO2004073651A3 Identifying inhibitors of intracellular protein fibrillization
08/04/2005WO2004066966A3 Peptide yy analogs
08/04/2005WO2004064782A3 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 295